Astria Therapeutics, Inc. (ATXS)
USD 5.36
(3.88%)
USD 5.36
(3.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 26 Thousand | 119 Thousand |
| Gross Profit | - | - | - | - | -26 Thousand | -119 Thousand |
| Operating Expenses | 83.03 Million | 53.5 Million | 30.35 Million | 37.43 Million | 27.08 Million | 26.37 Million |
| Selling, General and Administrative Expenses | 25.7 Million | 19.23 Million | 14.8 Million | 11.84 Million | 8.77 Million | 9.32 Million |
| Research and Development Expenses | 57.32 Million | 34.26 Million | 15.55 Million | 25.59 Million | 18.31 Million | 17.04 Million |
| Other Expenses | - | -55 Thousand | -58 Thousand | -101 Thousand | -50 Thousand | 176 Thousand |
| Cost and Expenses | 83.03 Million | 53.5 Million | 30.35 Million | 37.43 Million | 27.08 Million | 26.37 Million |
| Operating Income | -83.03 Million | -53.5 Million | -194.97 Million | -37.43 Million | -27.08 Million | -26.37 Million |
| Interest Expense | - | - | - | - | - | 100 Thousand |
| Income Tax Expense | - | -1.66 Million | -164.73 Million | -236 Thousand | -50 Thousand | 601 Thousand |
| Earnings before Tax | -72.89 Million | -51.83 Million | -194.91 Million | -37.3 Million | -26.29 Million | -25.87 Million |
| Net Income | -72.89 Million | -50.16 Million | -30.17 Million | -37.06 Million | -26.24 Million | -25.87 Million |
| Earnings Per Share Basic | -2.42 | -3.43 | -3.38 | -12.12 | -14.06 | -30.71 |
| Earnings Per Share Diluted | -2.42 | -3.43 | -3.38 | -12.12 | -14.06 | -30.71 |
| Weighted Average Shares Outstanding | 30.12 Million | 14.62 Million | 8.92 Million | 3.05 Million | 1.86 Million | 842.47 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 30.12 Million | 14.62 Million | 8.92 Million | 3.05 Million | 1.86 Million | 842.47 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -83.03 Million | -53.5 Million | -194.97 Million | -37.43 Million | -26.26 Million | -25.65 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 28.8 Million | 24.15 Million | 67.83 Million | 19 Million | 20.23 Million | 15.1 Million |
| Selling, General and Administrative Expenses | 8.09 Million | 8.42 Million | - | 7.33 Million | 6.89 Million | 6.01 Million |
| Research and Development Expenses | 20.7 Million | 15.72 Million | - | 11.66 Million | 13.33 Million | 9.08 Million |
| Other Expenses | -16 Thousand | -19 Thousand | 15.19 Million | -8000.00 | -18 Thousand | -20 Thousand |
| Cost and Expenses | 28.8 Million | 24.15 Million | 67.83 Million | 19 Million | 20.23 Million | 15.1 Million |
| Operating Income | -28.8 Million | -24.15 Million | -67.83 Million | -19 Million | -20.23 Million | -15.1 Million |
| Interest Expense | - | - | - | 2.3 Million | - | - |
| Income Tax Expense | - | -43.27 Thousand | 15.19 Thousand | 15.19 Thousand | 39.58 Thousand | -2.67 Million |
| Earnings before Tax | -24.17 Million | -19.92 Million | -72.89 Million | -31.41 Million | -17.72 Million | -12.56 Million |
| Net Income | -24.17 Million | -19.92 Million | -72.89 Million | -31.41 Million | -17.72 Million | -12.56 Million |
| Earnings Per Share Basic | -0.43 | -0.38 | - | -0.86 | -0.63 | -0.45 |
| Earnings Per Share Diluted | -0.43 | -0.38 | - | -0.86 | -0.63 | -0.45 |
| Weighted Average Shares Outstanding | 56.48 Million | 52.29 Million | 30.12 Million | 36.52 Million | 28.04 Million | 28.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.48 Million | 52.29 Million | 30.12 Million | 36.52 Million | 28.04 Million | 28.02 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -28.8 Million | -24.15 Million | - | -19 Million | -20.23 Million | -15.1 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CWR
TH1NG
600328
ALLEX
BRK-B
9501